For personal use only
1 February 2022
Australian Securities Exchange (ASX) Announcement
Appendix 4C - Supplementary Announcement
Further to the Appendix 4C released on 28 January 2022, the ASX, has requested the Company to release a supplementary announcement using the current ASX Appendix 4C template. Whilst the body of the Appendix 4C released on 28 January 2022 used the current ASX template, the footer inadvertently referred to a previous version of the Appendix 4C.
An updated Appendix 4C is attached with the revised footer, "ASX Listing Rules Appendix 4C (17/07/20)".
The Company confirms there is no new information or content disclosed in the Appendix 4C other than the amended footer.
-End-
Total Brain Limited | ABN 24 094 069 682
15 Belvoir Street, Surry Hills NSW 2021, Australia
ir@totalbrain.com | totalbrain.com
For personal use only
Rule 4.7B
Appendix 4C
Quarterly cash flow report for entities subject to Listing Rule 4.7B
Name of entity
Total Brain Limited | |
ABN | Quarter ended ("current quarter") |
24 094 069 682 | 31 Dec 2021 |
Consolidated statement of cash flows | Current quarter | Year to date | ||
$A'000 | (6 months) | |||
$A'000 | ||||
1. | Cash flows from operating activities | |||
1.1 | Receipts from customers | 3,961 | 4,515 | |
1.2 | Payments for | |||
(a) | research and development | - | - | |
(b) product manufacturing and operating | (227) | (506) | ||
costs | ||||
(c) | advertising and marketing | (177) | (440) | |
(d) | leased assets | - | - | |
(e) | staff costs | (2,208) | (4,611) | |
(f) administration and corporate costs | (299) | (773) | ||
1.3 | Dividends received (see note 3) | - | - | |
1.4 | Interest received | - | - | |
1.5 | Interest and other costs of finance paid | (133) | (133) | |
1.6 | Income taxes paid | - | - | |
1.7 | Government grants and tax incentives | - | - | |
1.8 | Other (provide details if material) | - | - | |
1.9 | Net cash from / (used in) operating | 917 | (1,948) | |
activities | ||||
2. | Cash flows from investing activities | |||
2.1 | Payments to acquire or for: | |||
(a) | entities | - | - | |
(b) | businesses | - | - | |
(c) property, plant and equipment | - | (10) | ||
(d) | investments | - | - | |
(e) | intellectual property | (950) | (2,351) | |
(f) | other non-current assets | - | - |
ASX Listing Rules Appendix 4C (17/07/20) | Page 1 |
+ See chapter 19 of the ASX Listing Rules for defined terms. |
For personal use only
Appendix 4C
Quarterly cash flow report for entities subject to Listing Rule 4.7B
Consolidated statement of cash flows | Current quarter | Year to date | ||
$A'000 | (6 months) | |||
$A'000 | ||||
2.2 | Proceeds from disposal of: | |||
(a) | entities | - | - | |
(b) | businesses | - | - | |
(c) property, plant and equipment | - | - | ||
(d) | investments | - | - | |
(e) | intellectual property | - | - | |
(f) | other non-current assets | - | - | |
2.3 | Cash flows from loans to other entities | - | - | |
2.4 | Dividends received (see note 3) | - | - | |
2.5 | Other (provide details if material) | - | - | |
2.6 | Net cash from / (used in) investing | (950) | (2,361) | |
activities | ||||
3. | Cash flows from financing activities | |||
3.1 | Proceeds from issues of equity securities | - | 6,523 | |
(excluding convertible debt securities) | ||||
3.2 | Proceeds from issue of convertible debt | - | - | |
securities | ||||
3.3 | Proceeds from exercise of options | - | - | |
3.4 | Transaction costs related to issues of | - | (472) | |
equity securities or convertible debt | ||||
securities | ||||
3.5 | Proceeds from borrowings | 2,197 | 2,197 | |
3.6 | Repayment of borrowings | (99) | (791) | |
3.7 | Transaction costs related to loans and | - | - | |
borrowings | ||||
3.8 | Dividends paid | - | - | |
3.9 | Other (provide details if material) | - | - | |
3.10 | Net cash from / (used in) financing | 2,098 | 7,457 | |
activities |
4. Net increase / (decrease) in cash and cash equivalents for the period
4.1 | Cash and cash equivalents at beginning of | 2,594 | 1,427 |
period | |||
4.2 | Net cash from / (used in) operating | 917 | (1,948) |
activities (item 1.9 above) | |||
4.3 | Net cash from / (used in) investing activities | (950) | (2,361) |
(item 2.6 above) | |||
4.4 | Net cash from / (used in) financing activities | 2,098 | 7,457 |
(item 3.10 above) |
ASX Listing Rules Appendix 4C (17/07/20) | Page 2 |
+ See chapter 19 of the ASX Listing Rules for defined terms. |
For personal use only
Appendix 4C
Quarterly cash flow report for entities subject to Listing Rule 4.7B
Consolidated statement of cash flows | Current quarter | Year to date | |
$A'000 | (6 months) | ||
$A'000 | |||
4.5 | Effect of movement in exchange rates on | (52) | 32 |
cash held | |||
4.6 | Cash and cash equivalents at end of | 4,607 | 4,607 |
period | |||
5. | Reconciliation of cash and cash | Current quarter | Previous quarter |
equivalents | $A'000 | $A'000 | |
at the end of the quarter (as shown in the | |||
consolidated statement of cash flows) to the | |||
related items in the accounts | |||
5.1 | Bank balances | 4,607 | 2,594 |
5.2 | Call deposits | - | - |
5.3 | Bank overdrafts | - | - |
5.4 | Other (provide details) | - | - |
5.5 | Cash and cash equivalents at end of | 4,607 | 2,594 |
quarter (should equal item 4.6 above) | |||
6. | Payments to related parties of the entity and their | Current quarter | |
associates | $A'000 | ||
6.1 | Aggregate amount of payments to related parties and their | 212 | |
associates included in item 1 | |||
6.2 | Aggregate amount of payments to related parties and their | - | |
associates included in item 2 |
Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments
Item 6.1 includes payments for remuneration of director fees to executive and non-executive directors in the normal course of business, excluding reimbursements of out-of-pocket expenses which is equivalent to the previous quarters expense
ASX Listing Rules Appendix 4C (17/07/20) | Page 3 |
+ See chapter 19 of the ASX Listing Rules for defined terms. |
Appendix 4C Quarterly cash flow report for entities subject to Listing Rule 4.7B
only
7. Financing facilities
Note: the term "facility' includes all forms of financing arrangements available to the entity.
Add notes as necessary for an understanding of the sources of finance available to the entity.
- Loan facilities
- Credit standby arrangements
- Other (please specify)
- Total financing facilities
Total facility | Amount drawn at |
amount at quarter | quarter end |
end | $A'000 |
$A'000 | |
3,388 | 3,388 |
- | - |
- | - |
3,388 | 3,388 |
For personal use
7.5 | Unused financing facilities available at quarter end | - |
7.6 Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.
On 25 June 2021, the company announced unsecured loans from current shareholders and an unrelated third-party. The loans were provided on an unsecured basis over 5 months at an interest rate of 12% per annum. The loans and accrued interest are repayable in cash during the term at the discretion of the company with no prepayment penalty, or otherwise is due at the end of the term. In the event of a capital raise during the term of the loans, and subject to applicable shareholder approvals required under the ASX listing rules and/or the Corporations Act 2001 (Cth), the lenders have the option to settle amounts owed with fully paid ordinary shares in the company at the price of the capital raise. Some of the loans were settled in the previous quarter with the outstanding balances pertaining to one shareholder and the unrelated third-party, their term extended to 18 March 2022.
On 7 Dec 2021, TTB received $2m of its anticipated $2.3m R&D tax incentive rebate under an agreement with Mitchell Asset Management Pty Ltd. Interest for the term is prepaid upon drawdown, at 1.1% per month. Early repayment of principal is allowed in full, with unearned interest refunded, subject to a minimum interest payment equivalent to three months term. The agreement is secured under a general security deed guaranteed by TTB subsidiary entities, terminates on 31 May 2022, with establishment costs and legal fees of less than $10,000 payable by TTB. The agreement includes customary default provisions.
8. | Estimated cash available for future operating activities | $A'000 |
8.1 | Net cash from / (used in) operating activities (Item 1.9) | 917 |
8.2 | Cash and cash equivalents at quarter end (Item 4.6) | 4,607 |
8.3 | Unused finance facilities available at quarter end (Item 7.5) | - |
8.4 | Total available funding (Item 8.2 + Item 8.3) | 4,607 |
8.5 | Estimated quarters of funding available (Item 8.4 divided by | N/A |
Item 8.1) | ||
Note: if the entity has reported positive net operating cash flows in item 1.9, answer item 8.5 as "N/A". Otherwise, a | ||
figure for the estimated quarters of funding available must be included in item 8.5. |
8.6 If Item 8.5 is less than 2 quarters, please provide answers to the following questions:
8.6.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?
Answer:
ASX Listing Rules Appendix 4C (17/07/20) | Page 4 |
+ See chapter 19 of the ASX Listing Rules for defined terms. |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Total Brain Limited published this content on 01 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 February 2022 04:41:01 UTC.